Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.350
+0.060 (4.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Evogene Employees
Evogene had 142 employees as of December 31, 2023. The number of employees increased by 5 or 3.65% compared to the previous year.
Employees
142
Change (1Y)
5
Growth (1Y)
3.65%
Revenue / Employee
$52,662
Profits / Employee
-$165,585
Market Cap
8.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
XWELL | 337 |
Viracta Therapeutics | 40 |
BioCardia | 20 |
Purple Biotech | 20 |
QT Imaging Holdings | 14 |
SeaStar Medical Holding | 12 |
COSCIENS Biopharma | 12 |
CERo Therapeutics Holdings | 9 |
EVGN News
- 4 weeks ago - Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Evogene Reports Third Quarter 2024 Financial Results - PRNewsWire
- 4 weeks ago - Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - PRNewsWire
- 5 weeks ago - Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials - PRNewsWire
- 6 weeks ago - Evogene Schedules Third Quarter 2024 Financial Results Release - PRNewsWire
- 7 weeks ago - Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - PRNewsWire
- 7 weeks ago - Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - PRNewsWire
- 2 months ago - Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PRNewsWire